Strategic partnership QXMédical recently announced a distribution partnership with Asahi Intecc USA for the Boosting Catheter, signaling a channel expansion opportunity to leverage distributor networks and accelerate market penetration in endovascular devices.

Expanded footprint The opening of a new state-of-the-art R&D and manufacturing facility in Roseville, MN indicates increased capacity and potential for faster product iterations, making QXMédical a viable partner for co-development and onshore supply opportunities.

Growth potential With annual revenue in the low single-digit millions and a small employee base, there is upside for scalable sales through larger healthcare providers and systems seeking innovative peripheral and coronary endovascular solutions.

Clinical impact QXMédical emphasizes novel endovascular technologies designed for high clinical impact, presenting a compelling value proposition for hospitals pursuing advanced treatments and physicians seeking confidence in device performance.

Quality and trust Compliance with ISO standards (ISO 13485 and ISO 17025) and a tech stack that supports regulatory and quality benchmarks position QXMédical as a reliable partner for procurement teams prioritizing quality, data integrity, and certifiable processes.